GT Biopharma, Inc. - 8-K Filing
GT Biopharma eliminates all series of preferred stock and implements a 1-for-25 reverse stock split effective September 8, 2026. (Items: 3.03 Material Modifications to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $GTBP